FFO
RVMD icon

Fortitude Family Office’s Revolution Medicines RVMD Stock Holding History

Fortitude Family Office’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.7K Sell
292
-4
-1% -$584 0.01% 275
2026
Q1 		$28.8K Buy
296
+68
+30% +$6.87K 0.01% 337
2025
Q4 		$18.2K Hold
228
– – ﹤0.01% 422
2025
Q3 		$10.6K Buy
228
+7
+3% +$274 ﹤0.01% 551
2025
Q2 		$8.13K Sell
221
-32
-13% -$1.23K ﹤0.01% 631
2025
Q1 		$8.95K Hold
253
– – ﹤0.01% 568
2024
Q4 		$11.1K Hold
253
– – ﹤0.01% 608
2024
Q3 		$11.5K Hold
253
– – ﹤0.01% 539
2024
Q2 		$9.82K Hold
253
– – 0.01% 417
2024
Q1 		$8.15K Hold
253
– – 0.01% 446
2023
Q4 		$7.26K Buy
+253
New +$6.08K 0.01% 492

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Fortitude Family Office's RVMD Position: Q2 2026 in Review

Fortitude Family Office reduced its Revolution Medicines (RVMD) stake by 1.4% in Q2 2026, selling an estimated $584 and leaving 292 shares worth $54.7K. The position accounts for 0.01% of the portfolio, ranked #275.

Fortitude Family Office first reported a position in RVMD in Q4 2023 and has held it in 11 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Fortitude Family Office held 292 shares of Revolution Medicines worth $54.7K as of Q2 2026.
  • Fortitude Family Office sold 4 Revolution Medicines shares in Q2 2026, an estimated $584.
  • Revolution Medicines made up 0.01% of Fortitude Family Office's portfolio in Q2 2026, its #275 holding.
  • Fortitude Family Office first reported a position in Revolution Medicines in Q4 2023 and has held it in 11 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.